Epidemiology & Biostatistics

The Marta  Łuksza Lab

Research

Marta  Łuksza
Marta  Łuksza, PhD
Member

The Łuksza Lab develops predictive models of immune-driven evolution to understand how tumors and viruses adapt under immune pressure. By integrating concepts from information theory, machine learning, statistical physics, and quantitative immunology, the lab builds computational frameworks to quantify immunogenicity, forecast therapy response, and optimize vaccine design. Led by Marta Łuksza, Ph.D., Associate Attending Member in the Computational Oncology Service at Memorial Sloan Kettering Cancer Center and affiliate of the Olayan Center for Cancer Vaccines, the group aims to anticipate evolutionary trajectories that inform precision immunotherapy and vaccine development. Dr. Łuksza is recognized for co-developing the influenza fitness model, which informs global vaccine strain selection, and for pioneering the neoantigen fitness model, which captures immunogenicity features of tumor mutations to predict patient response to checkpoint blockade therapy. At MSK, the lab’s interdisciplinary research bridges evolutionary modeling and translational oncology to guide data-driven decision-making in cancer immunotherapy and global public health.

People

Marta  Łuksza

Marta  Łuksza, PhD

Member

  • The Łuksza Lab develops predictive models of immune-driven evolution to understand how tumors and viruses adapt under immune pressure.
[email protected]
Email Address

Members

Matthijs Meijers
Matthijs Meijers
Research Scholar
Maria Ruiz Ortega
Research Scholar
Shayan Saniei
Research Associate
Marcus Thomas
Research Associate

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Marta  Łuksza discloses the following relationships and financial interests:

  • University of Cologne
    Professional Services and Activities
  • Wellcome Trust
    Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2025 through disclosure submission in spring 2026). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures